An initial clue supporting this hypothesis was provided by immunohistochemical (IHC) analyses of tumor sections; the abundance of CD33+ MDSCs was correlated to the level of LMP1 and glucose transporter 1 (GLUT1) expression in malignant epithelial cells. The gene discussed is SLC2A1; the disease is neoplasm.